Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia

Bone Marrow Transplant. 2024 Jan;59(1):144-146. doi: 10.1038/s41409-023-02138-6. Epub 2023 Oct 27.

Philip Wong^{1

2}, David C Whiteman^{2

3}, Catherine M Olsen^{2

3}, Yin Yuan¹, Jason Butler¹, Cameron Curley¹, Simon Durrant¹, Andrea Henden^{1

2

4}, James Morton¹, Elango Subramoniapillai¹, Caroline Stewart¹, Siok-Keen Tey^{1

4}, Glen A Kennedy¹, Ashleigh P Scott^{5

6}

¹ Department of Haematology and Bone Marrow Transplant, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
² Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.
³ Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
⁴ Translational Cancer Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
⁵ Department of Haematology and Bone Marrow Transplant, Royal Brisbane and Women's Hospital, Herston, QLD, Australia. Ashleigh.scott@health.qld.gov.au.
⁶ Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia. Ashleigh.scott@health.qld.gov.au.

No abstract available

Publication types